JPH033678B2 - - Google Patents

Info

Publication number
JPH033678B2
JPH033678B2 JP57129742A JP12974282A JPH033678B2 JP H033678 B2 JPH033678 B2 JP H033678B2 JP 57129742 A JP57129742 A JP 57129742A JP 12974282 A JP12974282 A JP 12974282A JP H033678 B2 JPH033678 B2 JP H033678B2
Authority
JP
Japan
Prior art keywords
hydroxy
methyl
androstan
androsten
ethylenedioxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP57129742A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5849400A (ja
Inventor
Bitsutoraa Deiitaa
Raurento Henrii
Nikishu Kurausu
Uiihieruto Rudorufu
Arupuringu Manfureeto
Shuroizenaa Annerooze
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of JPS5849400A publication Critical patent/JPS5849400A/ja
Publication of JPH033678B2 publication Critical patent/JPH033678B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/005—3 membered carbocyclic rings in position 12
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/008—3 membered carbocyclic rings in position 15/16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP57129742A 1981-07-29 1982-07-27 新規アンドロスタン誘導体 Granted JPS5849400A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19813130644 DE3130644A1 (de) 1981-07-29 1981-07-29 Neue androstan-derivate, verfahren zu ihrer herstellung und pharmazeutische praeparate, die diese verbindungen enthalten
DE3130644.6 1981-07-29

Publications (2)

Publication Number Publication Date
JPS5849400A JPS5849400A (ja) 1983-03-23
JPH033678B2 true JPH033678B2 (en, 2012) 1991-01-21

Family

ID=6138450

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57129742A Granted JPS5849400A (ja) 1981-07-29 1982-07-27 新規アンドロスタン誘導体

Country Status (17)

Country Link
US (2) US4457925A (en, 2012)
EP (1) EP0071153B1 (en, 2012)
JP (1) JPS5849400A (en, 2012)
AT (1) ATE22086T1 (en, 2012)
AU (1) AU558412B2 (en, 2012)
CA (1) CA1210754A (en, 2012)
DE (2) DE3130644A1 (en, 2012)
DK (1) DK164325B (en, 2012)
ES (1) ES8305003A1 (en, 2012)
FI (1) FI78110C (en, 2012)
GB (1) GB2104899B (en, 2012)
GR (1) GR76872B (en, 2012)
IE (1) IE53711B1 (en, 2012)
IL (1) IL66311A (en, 2012)
NO (1) NO159661C (en, 2012)
PT (1) PT75334B (en, 2012)
ZA (1) ZA825480B (en, 2012)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3331824A1 (de) * 1983-09-01 1985-03-21 Schering AG, Berlin und Bergkamen, 1000 Berlin Verfahren zur herstellung von 17(alpha)-acyloxy-6-chlor-1(alpha),2(alpha)-methylen-3,20-dionen
DE3347126A1 (de) * 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen 11ss-aryl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
US4720489A (en) * 1984-10-15 1988-01-19 Douglas Shander Hair growth modification with ornithine decarboxylase inhibitors
JPS61286185A (ja) * 1985-06-13 1986-12-16 Yoshizo Koishi 刻印装置
DE3824247A1 (de) * 1988-07-13 1990-01-18 Schering Ag Neue androstan-derivate
GB9021546D0 (en) * 1990-10-04 1990-11-21 Beecham Group Plc Novel composition
DE4102244A1 (de) * 1991-01-24 1992-07-30 Schering Ag 14,16ss-ethano-15ss, 16(pfeil hoch)1(pfeil hoch)-cyclo-14ss-estra-1,3,5(10)-triene
US6743419B1 (en) 1992-12-22 2004-06-01 The Gillette Company Method of reducing hair growth employing sulfhydryl active compounds
US5411991A (en) * 1992-12-22 1995-05-02 Shander; Douglas Method of reducing hair growth employing sulfhydryl active compounds
US20040242618A1 (en) * 2003-04-01 2004-12-02 Lardy Henry A. Antiandrogens with marginal agonist activity and methods of use
US8084446B2 (en) 2005-04-26 2011-12-27 Eric Marchewitz Use of DHEA derivatives for enhancing physical performance
US20130123523A1 (en) * 2011-11-10 2013-05-16 Klaus Nickisch Methods for the preparation of etonogestrel and desogestrel

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR7871M (en, 2012) * 1968-11-13 1970-04-27
DE2644427A1 (de) * 1976-09-30 1978-04-06 Schering Ag 17 beta-hydroxy-17 alpha-(3-acyloxypropyl)-4.6-androstadien-3-one und deren salze
CH631462A5 (de) * 1976-03-05 1982-08-13 Schering Ag Verfahren zur herstellung von neuen steroiden der androstan- oder oestranreihe.
DE2722706A1 (de) * 1977-05-16 1978-12-07 Schering Ag 15.16-methylen-androsta-4.15-dien- 3-one und verfahren zu ihrer herstellung
ES469510A1 (es) * 1977-05-16 1978-12-01 Schering Ag Procedimiento para la preparacion de 17beta hidroxi-4-an- drosten-3-onas.

Also Published As

Publication number Publication date
IE53711B1 (en) 1989-01-18
IL66311A (en) 1986-03-31
NO159661B (no) 1988-10-17
PT75334B (de) 1984-07-31
GB2104899B (en) 1985-01-30
AU558412B2 (en) 1987-01-29
ZA825480B (en) 1983-11-30
US4587235A (en) 1986-05-06
PT75334A (de) 1982-08-01
FI822658L (fi) 1983-01-30
ATE22086T1 (de) 1986-09-15
ES514492A0 (es) 1983-04-16
GB2104899A (en) 1983-03-16
EP0071153A1 (de) 1983-02-09
DK164325B (da) 1992-06-09
DE3273186D1 (en) 1986-10-16
ES8305003A1 (es) 1983-04-16
DK327082A (da) 1983-01-30
NO159661C (no) 1989-01-25
AU8643982A (en) 1984-10-18
FI78110C (fi) 1989-06-12
DE3130644A1 (de) 1983-02-17
IL66311A0 (en) 1982-11-30
CA1210754A (en) 1986-09-02
NO822596L (no) 1983-01-31
JPS5849400A (ja) 1983-03-23
US4457925A (en) 1984-07-03
EP0071153B1 (de) 1986-09-10
FI822658A0 (fi) 1982-07-29
FI78110B (fi) 1989-02-28
IE821824L (en) 1983-01-29
GR76872B (en, 2012) 1984-09-04

Similar Documents

Publication Publication Date Title
EP0097572B1 (fr) Nouveaux 19-nor stéroides substitués en 11 et éventuellement en 2,leur préparation, leur application comme médicaments, les compositions les renfermant et les nouveaux intermédiaires obtenus
KR0161975B1 (ko) 11베타-치환 프로게스테론 유사체
WO1983003099A1 (en) 3-keto-delta 4,9-19-norsteroids
FI95711B (fi) Menetelmä terapeuttisesti käyttökelpoisten 4-substituoitujen 17 -(syklopropyylioksi)androst-5-eenijohdannaisten valmistamiseksi, jotka ovat hyödyllisiä C17-20-lyaasi-inhibiittoreina
JPS61194096A (ja) １１β‐アリール‐エストラジエン、その製法及びこれを含有する抗ゲスターゲン及び抗糖質コルチコイド製剤
JPH033678B2 (en, 2012)
US4075233A (en) 16-Dehydro steroids of the androstane series
IE41524B1 (en) Novel haptene derivatives of estrogens process for prepariing them and methods of preparing antigens from them
US4808578A (en) 6-Alkylidene 10 β-alkynylestrene derivatives and pharmaceutical methods for their use
US6784170B2 (en) Synthesis of anti-estrogenic and other therapeutic steroids from 21-hydroxy-19-norpregna-4-en-3-one
JPH069685A (ja) １７位にメチレンラクトン基を含有する新規なステロイド、それらの製造法及び中間体、それらの薬剤としての使用並びにそれらを含有する製薬組成物
PT1831239E (pt) Processo para a preparação de γ-lactona do ácido 17- hidroxi-6β, 7β; 15β, 16β-bismetileno-17α- pregn-4-eno-3- ona-21 carboxílico e intermediários chave para este processo
US4789671A (en) 14,17β-ethano-14β-estratrienes and estratetraenes, process for their production, and pharmaceutical preparations containing them
JP2999258B2 (ja) １０β―Ｈ―ステロイドの製法
JP3135564B2 (ja) １１β―置換１６α，１７α―メチレン―エストラ―４，９―ジエン―３―オン
JPS6321680B2 (en, 2012)
JPS636559B2 (en, 2012)
JPS6360035B2 (en, 2012)
US4607054A (en) Antiandrogenic compositions containing indene-7-ones
US4303654A (en) Novel 21-chloro-20-acetylenic steroids
US3087941A (en) 17alpha-bromo-6-methyl-pregnane derivatives
US3325536A (en) C-norpregnanes
US3325535A (en) C-norsteroids
JPH0212237B2 (en, 2012)
US20070249573A1 (en) 17alpha-substituted 4-(3-oxoestra-4,9-dien-11beta-yl)-benzoic acid, its derivatives and process for its production